Dermatologic Manifestations of Zika Virus

Overview

The purpose of this study is to determine whether any diagnostic patterns exist in the symptom presentation of Zika Virus.

Full Title of Study: “Survey of Symptoms and Dermatologic Characterization Associated With Zika Virus”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 31, 2018

Detailed Description

The study has both retrospective and prospective components. The retrospective review includes medical records with laboratory confirmed Zika Virus diagnosis and the prospective component will enroll adults presenting with febrile illness and rash and ask them to complete a survey about their symptoms. Diagnostic testing will be completed to confirm infection source.

Interventions

  • Other: Survey
    • 18 question symptom assessment tool including non-identifying demographic information questions.

Clinical Trial Outcome Measures

Primary Measures

  • Number of days with specific symptoms
    • Time Frame: 20 minutes
    • Number of days reported experiencing specific symptoms due to Zika Virus infection and and associated characteristics such as location and intensity

Secondary Measures

  • Frequency measures of initial clinical presentations
    • Time Frame: 20 minutes
    • Frequency of reported symptoms at initial clinical presentation.

Participating in This Clinical Trial

Inclusion Criteria

  • Adults aged 18 years and older presenting with febrile illness and rash Exclusion Criteria:

  • Patients aged 17 years or younger

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Northwestern University
  • Collaborator
    • Pontificia Universidad Catolica Madre y Maestra
  • Provider of Information About this Clinical Study
    • Principal Investigator: Roopal Kundu, Principal Investigator – Northwestern University
  • Overall Official(s)
    • Roopal V. Kundu, MD, Principal Investigator, Northwestern University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.